[1]
Fadhil, H.R. et al. 2023. Comparison between Reference Infliximab (Remicade) and its Biosimilar (Remsima) in Patients with Ankylosing Spondylitis: A Field-based Pharmacoeconomic Study . AL-Kindy College Medical Journal. 19, 1 (Apr. 2023), 100–105. DOI:https://doi.org/10.47723/kcmj.v19i1.908.